Sign in

    Brian Chung • JPMorgan Chase & Co.

    Brian Chung is a Market Risk Analyst at JPMorgan Chase & Co., with a focus on quantitative analysis and risk management strategies in the finance sector. While currently there are no public records of specific company coverage or performance metrics such as TipRanks rankings, his expertise centers on market risk assessment across a range of investment portfolios. Brian Chung began his career after graduating from Diablo Valley College, with experience in roles such as Math & Computer Science Tutor prior to joining JPMorgan Chase. Professional credentials or securities licenses are not publicly reported for him at this time.

    Brian Chung's questions to Coherus BioSciences Inc (CHRS) leadership

    Brian Chung's questions to Coherus BioSciences Inc (CHRS) leadership • Q2 2025

    Question

    Brian Chung of JPMorgan Chase & Co. inquired about the importance and timing of securing a partner for the CHS-114 (anti-CCR8) program and asked for an update on the company's confidence in achieving its $150M-$200M revenue goal for Loktorzi.

    Answer

    Chief Medical Officer Rosh Dias outlined the data readout timeline for CHS-114, expecting efficacy and safety data in H1 2026. CEO Dennis Lanfear and Chief Scientific & Development Officer Theresa Lavallee emphasized their focus on finding the right partner to maintain development speed and leverage the asset's broad combinability. EVP of Commercial Sameer Goregaoker expressed high confidence in the Loktorzi revenue target, citing the strong uptake in academic centers following NCCN guideline updates as a key positive indicator.

    Ask Fintool Equity Research AI